Implementing a Mobile Stroke Unit Program in the United States Why, How, and How Much?

被引:51
作者
Rajan, Suja [1 ]
Baraniuk, Sarah [1 ]
Parker, Stephanie [2 ]
Wu, Tzu-Ching [2 ]
Bowry, Ritvij [3 ]
Grotta, James C. [3 ]
机构
[1] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA
[2] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA
[3] Mem Hermann Texas Med Ctr, Houston, TX 77030 USA
关键词
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; COST-EFFECTIVENESS; POOLED ANALYSIS; TIME; THROMBOLYSIS; NINDS; PA; TELEMEDICINE; ASSOCIATION;
D O I
10.1001/jamaneurol.2014.3618
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IMPORTANCE There are many ways a mobile stroke unit (MSU) might prove valuable for patients with ischemic and hemorrhagic stroke, such as earlier recognition, more accurate triage, improved management of blood pressure and other critical physiological variables, and eventually earlier implementation of effective therapies. The MSU may be particularly valuable for treatment of patients with acute ischemic stroke with tissue plasminogen activator (tPA) within 4.5 hours of symptom onset, the most evidence-based effective emergency treatment for the most prevalent stroke diagnosis. OBJECTIVES To review existing data on prehospital stroke treatment, especially relevant to MSU technology, to identify gaps in our understanding of MSU feasibility, especially relevant to applying the MSU strategy in the United States, and to describe the Houston MSU program and clinical trial. EVIDENCE REVIEW Published data from English-language journals in PubMed from 1995 to present reviewing early treatment with tPA and prehospital stroke evaluation and treatment. FINDINGS The MSU may result in an overall shift toward earlier evaluation and treatment with tPA, particularly into the first hour after symptom onset, leading to substantially better outcomes. As a result of improved clinical outcomes owing to earlier treatment, the costs of an MSU program may be offset by a reduction in the costs of long-term stroke care and an increase in quality-adjusted life-years, thereby supporting more widespread use of this technology. To make MSU deployment more practical, the vascular neurologist aboard the MSU must be replaced by a remote vascular neurologist connected to the MSU by telemedicine, reducing manpower requirements and costs. CONCLUSIONS AND RELEVANCE The MSU strategy could dramatically transform the way acute stroke is managed in the United States. A prospective study evaluating the logistics, outcomes, and cost-effectiveness of this approach is needed and under way.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 26 条
  • [1] [Anonymous], 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]
  • [2] Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
    Broderick, Joseph P.
    Palesch, Yuko Y.
    Demchuk, Andrew M.
    Yeatts, Sharon D.
    Khatri, Pooja
    Hill, Michael D.
    Jauch, Edward C.
    Jovin, Tudor G.
    Yan, Bernard
    Silver, Frank L.
    von Kummer, Ruediger
    Molina, Carlos A.
    Demaerschalk, Bart M.
    Budzik, Ronald
    Clark, Wayne M.
    Zaidat, Osama O.
    Malisch, Tim W.
    Goyal, Mayank
    Schonewille, Wouter J.
    Mazighi, Mikael
    Engelter, Stefan T.
    Anderson, Craig
    Spilker, Judith
    Carrozzella, Janice
    Ryckborst, Karla J.
    Janis, L. Scott
    Martin, Renee H.
    Foster, Lydia D.
    Tomsick, Thomas A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) : 893 - 903
  • [3] Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI [10.1056/NEJMoa1213701, 10.1056/NEJMc1304759]
  • [4] Spending and service use among people with the fifteen most costly medical conditions, 1997
    Cohen, JW
    Krauss, NA
    [J]. HEALTH AFFAIRS, 2003, 22 (02) : 129 - 138
  • [5] Effect of the Use of Ambulance-Based Thrombolysis on Time to Thrombolysis in Acute Ischemic Stroke A Randomized Clinical Trial
    Ebinger, Martin
    Winter, Benjamin
    Wendt, Matthias
    Weber, Joachim E.
    Waldschmidt, Carolin
    Rozanski, Michal
    Kunz, Alexander
    Koch, Peter
    Kellner, Philipp A.
    Gierhake, Daniel
    Villringer, Kersten
    Fiebach, Jochen B.
    Grittner, Ulrike
    Hartmann, Andreas
    Mackert, Bruno-Marcel
    Endres, Matthias
    Audebert, Heinrich J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16): : 1622 - 1631
  • [6] Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
    Fagan, SC
    Morgenstern, LB
    Petitta, A
    Ward, RE
    Tilley, BC
    Marler, JR
    Levine, SR
    Broderick, JP
    Kwiatkowski, TG
    Frankel, M
    Brott, TG
    Walker, MD
    [J]. NEUROLOGY, 1998, 50 (04) : 883 - 890
  • [7] Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative
    Fonarow, Gregg C.
    Zhao, Xin
    Smith, Eric E.
    Saver, Jeffrey L.
    Reeves, Mathew J.
    Bhatt, Deepak L.
    Xian, Ying
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16): : 1632 - 1640
  • [8] Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes
    Fonarow, Gregg C.
    Smith, Eric E.
    Saver, Jeffrey L.
    Reeves, Mathew J.
    Bhatt, Deepak L.
    Grau-Sepulveda, Maria V.
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    [J]. CIRCULATION, 2011, 123 (07) : 750 - U184
  • [9] Hacke W, 2004, LANCET, V363, P768
  • [10] Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
    Jauch, Edward C.
    Saver, Jeffrey L.
    Adams, Harold P., Jr.
    Bruno, Askiel
    Connors, J. J.
    Demaerschalk, Bart M.
    Khatri, Pooja
    McMullan, Paul W., Jr.
    Qureshi, Adnan I.
    Rosenfield, Kenneth
    Scott, Phillip A.
    Summers, Debbie R.
    Wang, David Z.
    Wintermark, Max
    Yonas, Howard
    [J]. STROKE, 2013, 44 (03) : 870 - 947